影像引导经皮微波消融治疗不可切除胰腺癌:一项多中心回顾性研究
该多中心回顾性研究纳入2009年11月至2022年10月四家医院的72例不可切除胰腺癌患者,评估影像引导经皮微波消融的可行性、有效性和安全性。技术成功率100%,完全消融率40.5%,疼痛缓解率96.7%,平均疼痛评分从术前6.3降至术后2.0(P<0.001)。结论认为该治疗安全可行,能有效缓解癌痛并改善生活质量。
要点
- 影像引导经皮微波消融治疗不可切除胰腺癌的技术成功率达100%。
- 完全消融率为40.5%(30/74),疼痛缓解率达96.7%(32/33)。
- 平均疼痛评分从术前6.3降至术后2.0(P<0.001)。
核心结论
- 影像引导经皮微波消融治疗不可切除胰腺癌安全可行,能有效缓解癌痛并改善患者生活质量。
研究设计与样本
- 多中心回顾性研究,纳入四家医院72例不可切除胰腺癌患者,26例采用CT引导、46例采用超声引导,共74个肿瘤、73次消融。
诊断标准与关键数值
- 完全消融率40.5%(30/74),技术成功率100%,疼痛缓解率96.7%(32/33),中位随访4.6(1-43.4)个月,中位总生存期5.6(1-27)个月。
临床应用与阅片要点
- 术前33例有疼痛症状者术后疼痛缓解率96.7%,平均疼痛评分由6.3(4-10)降至2.0(0-8)(P<0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: This study aims to assess the feasibility, effectiveness, and safety of image-guided percutaneous microwave ablation (PMWA) for unresectable pancreatic cancer.
METHODS: In this retrospective study, 72 patients from four hospitals were enrolled between November 2009 and October 2022. Descriptive statistics were employed to describe the patients' characteristics and prognostic factors. The primary endpoint compassed the complete ablation rate (CAR), incidence of complications and the pain relief rate (PRR).
RESULTS: The median age of the 72 patients was 61 (interquartile range (IQR) 52.5-67.0) years, with 62.5 % (45/72) being male. 26 cases received computed tomography (CT) guidance; 46 cases received ultrasound guidance. A total of 74 tumors were identified (2 in 2 patients), with 56.8 % (42/74) at the body and tail, and the rest at the head and neck. Overall, 73 ablation sessions were carried out, achieving a technical success rate (TSR) of 100 %. The CAR was 40.5 % (30/74). The median follow-up time was 4.6 (1-43.4) months. 50 % (36/72) of patients had died with a median overall survival (OS) of 5.6 (1-27) months. Regarding complications, 18.1 % (13/72) of cases were classified as grade I and II, and 9.8 % (7/72) as grade IIIa. Before surgery, 33 patients experienced pain symptoms, and the postoperative PRR was 96.7 % (32/33). The average pain score decreased from 6.3 (4-10) before surgery to 2.0 (0-8) after ablation (P<0.001).
CONCLUSIONS: Image-guided PMWA for unresectable pancreatic cancer is safe and feasible, effectively relieving cancer pain and improving patients' the quality of life.
引用
- Zhou J, Dong G, Jing X, et al. Image-guided percutaneous microwave ablation for unresectable pancreatic cancers: A multicenter retrospective study. Eur J Radiol. 2024. PMID: 39326234. doi:10.1016/j.ejrad.2024.111720
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。